knowledge -WSS

knowledge

author：comprehensive 2025-10-01 21:35:09 - browse：47158

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Bispecific antibodies are next new thing in cancer immunotherapy

leisure time

knowledge

WSS

How to fix the rural physician shortage in the U.S.

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Timeline: Key moments in fight for gay rights

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Decaf coffee targeted by food safety group under obscure FDA rule

The thinking behind the controversial eating disorder chatbot Tessa

hotspot

knowledge

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Malaria cases in Florida and Texas: Here’s what you need to know

Xenotransplantation trials will require adjusting expectations, experts say

In age of alternative facts, a scholarly course on calling out crap

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Novavax promises a turnaround & Lilly roils the obesity market

Novo pauses ads for weight loss drug Wegovy amid demand

entertainment

Millions may soon lose Medicaid when they don't have to

Roche subsidiary Foundation Medicine opens new headquarters

Novo: Oral version of Ozempic leads to 15% weight loss

Altering the blood type of lungs raises potential for universal organs for transplants

Study says nonprofit hospitals fall short in charity care spending

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

entertainment

leisure time

knowledge

Wikipedia